Danish Life Science Leaders and US Investors to Meet on Cross-Border Development
DKBIO 2018, Sponsored by the Consulate General of Denmark and Back Bay Life Science Advisors, will Highlight Global Innovation and Collaboration in Biotech
BOSTON, MA, March 28, 2018 – Back Bay Life Science Advisors today announces that it is co-sponsoring DKBIO 2018: Danish Science and the City. For the first time in Boston, 17 leading Danish life science companies will convene with top-tier American life science investors and scientific collaborators on April 10 – 11 at Harvard Medical School to discuss cross-border development between biotech communities in Copenhagen and Boston.Now in its third year, DKBIO provides an intimate forum for Danish and American life science executives to come together to discuss innovation and collaboration in the globalization of biotech.“Life science success comes to those who extend across borders with the right partners in development and commercialization,” said Dr. Jonathan P. Gertler, managing partner and CEO of Back Bay Life Science Advisors. “For more than a decade, Back Bay has fostered relationships within the Boston and Danish ecosystems. We are a leader in cross-border life science collaboration in the Nordic region and have unique experience and perspective on the value of partnerships across a global life science stage.”Launched in New York in 2016, DKBIO showcases Danish life science excellence to the American investment community and explores openings for further engagement between the two. While global in nature, the conference – which includes panels and fireside chats – will strike an intimate note with experts such as Mike Lebel, Executive Director of Business Development at Celgene Corp., Mary Lynne Hedley, Co-Founder of TESARO, and Kasim Kutay, CEO of Novo Holdings A/S, addressing areas of collaboration and growth in the life sciences.In addition Back Bay Life Science Advisors, DKBIO is backed by Danish sponsors such as Novo Holdings A/S and Lundbeckfonden and U.S. collaborators including McGuireWoods, Nasdaq, EY and Solebury Trout.DKBIO 2018 takes place at the Joseph B. Martin Conference Center at Harvard Medical School April 10 - 11. Life science professionals may register here.
About Back Bay Life Science Advisors
Back Bay Life Science Advisors is a strategic consulting and financial advisory firm dedicated to uncovering the deepest business insights for clients so they can thrive in a competitive, dynamic environment. We advance those recommendations into execution on the transactions that drive our industry. Back Bay combines rigorous analytics and industry expertise to arrive at solutions that are often unexpected but always realistic and actionable.Back Bay’s hands-on senior leaders are engaged with every assignment, from inception to execution. To learn more about Back Bay leadership visit bblsa.com.
Follow us on LinkedInSubscribe to our newsletterWatch our video to learn more about Back Bay PRESS CONTACT: Jocelyn MillerBack Bay Life Science Advisorsjmiller@bblsa.com or bblsa@matternow.com781-254-9273